Search Results

There are 20394 results for: content related to: High levels of CD 20 expression predict good prognosis in chronic lymphocytic leukemia

  1. You have full text access to this OnlineOpen article
    De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: Molecular mechanisms and correlation with rituximab sensitivity

    Cancer Science

    Volume 105, Issue 1, January 2014, Pages: 35–43, Takashi Tokunaga, Akihiro Tomita, Keiki Sugimoto, Kazuyuki Shimada, Chisako Iriyama, Tatsuya Hirose, Mizuho Shirahata-Adachi, Yasuhiro Suzuki, Hiroki Mizuno, Hitoshi Kiyoi, Naoko Asano, Shigeo Nakamura, Tomohiro Kinoshita and Tomoki Naoe

    Version of Record online : 22 DEC 2013, DOI: 10.1111/cas.12307

  2. You have full text access to this Open Access content
    Comparison of CD20 expression in B-cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1567–1573, Hiroaki Miyoshi, Fumiko Arakawa, Kensaku Sato, Yoshizo Kimura, Junichi Kiyasu, Masanori Takeuchi, Maki Yoshida, Ayako Ichikawa, Yukinao Ishibashi, Yukihiko Nakamura, Shinji Nakashima, Daisuke Niino, Yasuo Sugita and Koichi Ohshima

    Version of Record online : 17 MAY 2012, DOI: 10.1111/j.1349-7006.2012.02307.x

  3. You have full text access to this OnlineOpen article
    Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation

    Cancer Science

    Volume 107, Issue 5, May 2016, Pages: 682–689, Kazumi Hayashi, Eijiro Nagasaki, Shin Kan, Masaki Ito, Yuko Kamata, Sadamu Homma and Keisuke Aiba

    Version of Record online : 7 APR 2016, DOI: 10.1111/cas.12918

  4. CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma

    European Journal of Haematology

    Volume 89, Issue 4, October 2012, Pages: 350–355, Tsuyoshi Nakamaki, Kunihiko Fukuchi, Hidetoshi Nakashima, Hirotsugu Ariizumi, Takashi Maeda, Bungo Saito, Kouji Yanagisawa, Shigeru Tomoyasu, Mayumi Homma, Eisuke Shiozawa, Toshiko Yamochi-Onizuka and Hidekazu Ota

    Version of Record online : 25 AUG 2012, DOI: 10.1111/j.1600-0609.2012.01838.x

  5. You have free access to this content
    Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells

    American Journal of Hematology

    Volume 89, Issue 7, July 2014, Pages: 757–765, Clive S. Zent, Ronald P. Taylor, Margaret A. Lindorfer, Paul V. Beum, Betsy LaPlant, Wenting Wu, Timothy G. Call, Deborah A. Bowen, Michael J. Conte, Lori A. Frederick, Brian K. Link, Sue E. Blackwell, Suresh Veeramani, Nisar A. Baig, David S. Viswanatha, George J. Weiner and Thomas E. Witzig

    Version of Record online : 26 APR 2014, DOI: 10.1002/ajh.23737

  6. You have free access to this content
    Bone marrow stromal mesenchymal cells induce down regulation of CD20 expression on B-CLL: implications for rituximab resistance in CLL

    British Journal of Haematology

    Volume 169, Issue 2, April 2015, Pages: 211–218, Maria-Elena Marquez, Octavio Hernández-Uzcátegui, Alejandro Cornejo, Paula Vargas and Osiris Da Costa

    Version of Record online : 22 JAN 2015, DOI: 10.1111/bjh.13286

  7. You have free access to this content
    Consistent, multi-instrument single tube quantification of CD20 in antibody bound per cell based on CD4 reference

    Cytometry Part B: Clinical Cytometry

    Volume 90, Issue 2, March 2016, Pages: 159–167, Heba Degheidy, Fatima Abbasi, Howard Mostowski, Adolfas K. Gaigalas, Gerald Marti, Steven Bauer and Lili Wang

    Version of Record online : 6 JUL 2015, DOI: 10.1002/cyto.b.21253

  8. You have full text access to this OnlineOpen article
    Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others

    Cancer Medicine

    Volume 2, Issue 2, April 2013, Pages: 130–143, Hideaki Kobayashi, Yuka Matsunaga, Yumiko Uchiyama, Kenji Nagura and Yasuhiko Komatsu

    Version of Record online : 20 FEB 2013, DOI: 10.1002/cam4.60

  9. You have free access to this content
    Down-regulation of CD20 on B cells upon CD40 activation

    European Journal of Immunology

    Volume 33, Issue 9, September 2003, Pages: 2398–2409, Jennifer Anolik, R. John Looney, Andrea Bottaro, Iñaki Sanz and Fay Young

    Version of Record online : 4 AUG 2003, DOI: 10.1002/eji.200323515

  10. You have free access to this content
    PUBLICATION

    Hematological Oncology

    Volume 31, Issue S1, June 2013, Pages: 201–270,

    Version of Record online : 17 JUN 2013, DOI: 10.1002/hon.2059

  11. Subepithelial dendritic B cells in orofacial granulomatosis

    Inflammatory Bowel Diseases

    Volume 16, Issue 6, June 2010, Pages: 1051–1060, Pritash Patel, Francesca Barone, Carlo Nunes, Laurent Boursier, Edward Odell, Michael Escudier, Stephen Challacombe, Jonathan Brostoff, Jo Spencer and Jeremy Sanderson

    Version of Record online : 18 NOV 2009, DOI: 10.1002/ibd.21169

  12. You have full text access to this Open Access content
    Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma

    Cancer Science

    Volume 104, Issue 1, January 2013, Pages: 105–110, Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Toshiki Uchida, Tatsuya Suzuki, Yukio Kobayashi, Masakazu Mori, Yasuhito Terui, Masahiro Yokoyama and Tomomitsu Hotta

    Version of Record online : 12 NOV 2012, DOI: 10.1111/cas.12040

  13. You have full text access to this Open Access content
    Tailored immunoconjugate therapy depending on a quantity of tumor stroma

    Cancer Science

    Volume 104, Issue 2, February 2013, Pages: 231–237, Masahiro Yasunaga, Shino Manabe, David Tarin and Yasuhiro Matsumura

    Version of Record online : 16 DEC 2012, DOI: 10.1111/cas.12062

  14. You have free access to this content
    Combined normal donor and CLL: Single tube ZAP-70 analysis

    Cytometry Part B: Clinical Cytometry

    Volume 82B, Issue 2, March 2012, Pages: 67–77, Heba A. Degheidy, David J. Venzon, Mohammed Z. H. Farooqui, Fatima Abbasi, Diane C. Arthur, Wyndham H. Wilson, Adrian Wiestner, M. A. Stetler-Stevenson and Gerald E. Marti

    Version of Record online : 26 OCT 2011, DOI: 10.1002/cyto.b.20622

  15. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: A clinicopathologic study

    Pathology International

    Volume 64, Issue 7, July 2014, Pages: 336–345, Ahmed Ali Elsayed, Naoko Asano, Koichi Ohshima, Koji Izutsu, Tomohiro Kinoshita and Shigeo Nakamura

    Version of Record online : 21 JUL 2014, DOI: 10.1111/pin.12175

  16. You have free access to this content
    Depletion of functionally active CD20+ T cells by rituximab treatment

    Arthritis & Rheumatism

    Volume 60, Issue 12, December 2009, Pages: 3563–3571, Esther Wilk, Torsten Witte, Nicole Marquardt, Tibor Horvath, Katy Kalippke, Kirsten Scholz, Nadine Wilke, Reinhold E. Schmidt and Roland Jacobs

    Version of Record online : 30 NOV 2009, DOI: 10.1002/art.24998

  17. You have free access to this content
    Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis

    Clinical & Experimental Immunology

    Volume 139, Issue 3, March 2005, Pages: 439–446, E. Janas, R. Priest, J. I. Wilde, J. H. White and R. Malhotra

    Version of Record online : 7 FEB 2005, DOI: 10.1111/j.1365-2249.2005.02720.x

  18. You have free access to this content
    Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: Evidence from phenotyping after rituxan therapy and transfectant cell analyses

    Cytometry

    Volume 46, Issue 2, 15 April 2001, Pages: 98–104, Stefan Serke, Ingo Schwaner, Maya Yordanova, Agnes Szczepek and Dieter Huhn

    Version of Record online : 12 APR 2001, DOI: 10.1002/cyto.1071

  19. You have free access to this content
    The need for markers and predictors of Rituximab treatment resistance

    Experimental Dermatology

    Volume 23, Issue 4, April 2014, Pages: 236–237, Cassian Sitaru and Jens Thiel

    Version of Record online : 16 FEB 2014, DOI: 10.1111/exd.12331

  20. You have full text access to this Open Access content
    Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope

    Cancer Science

    Volume 101, Issue 1, January 2010, Pages: 201–209, Susumu Uchiyama, Yasuhiko Suzuki, Kentaro Otake, Masami Yokoyama, Mitsuo Ohta, Shuichi Aikawa, Midori Komatsu, Tetsuji Sawada, Yoshitoyo Kagami, Yasuo Morishima and Kiichi Fukui

    Version of Record online : 10 OCT 2009, DOI: 10.1111/j.1349-7006.2009.01392.x